Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015, Article ID 923762, 20 pages
http://dx.doi.org/10.1155/2015/923762
Research Article

Modeling the Interaction between β-Amyloid Aggregates and Choline Acetyltransferase Activity and Its Relation with Cholinergic Dysfunction through Two-Enzyme/Two-Compartment Model

1Department of Mathematics and Statistics, University of Guelph, Guelph, ON, Canada N1G 2W1
2Biomedical Engineering Department, Faculty of Engineering at Helwan, Helwan University, Helwan, Cairo 11792, Egypt
3Chemical Engineering Department, University of Waterloo, Waterloo, ON, Canada N2L 3G1

Received 25 March 2015; Accepted 14 July 2015

Academic Editor: David A. Winkler

Copyright © 2015 Hedia Fgaier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. S. Lips, J. Wunsch, S. Zarghooni et al., “Acetylcholine and molecular components of its synthesis and release machinery in the urothelium,” European Urology, vol. 51, no. 4, pp. 1042–1053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Nachmansohn and A. L. Machado, “The formation of acetylcholine. A new enzyme choline acetylase,” Journal of Neurophysiology, vol. 6, pp. 397–403, 1943. View at Google Scholar
  3. Y. Oda, “Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system,” Pathology International, vol. 49, no. 11, pp. 921–937, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Abreu-Villaça, C. C. Filgueiras, and A. C. Manhães, “Developmental aspects of the cholinergic system,” Behavioural Brain Research, vol. 221, no. 2, pp. 367–378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. I. H. Mustafa, G. Ibrahim, A. Elkamel, S. S. E. H. Elnashaie, and P. Chen, “Non-linear feedback modeling and bifurcation of the acetylcholine neurocycle and its relation to Alzheimer's and Parkinson's diseases,” Chemical Engineering Science, vol. 64, no. 1, pp. 69–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. I. H. Mustafa, A. Elkamel, G. Ibrahim, P. Chen, and S. S. E. H. Elnashaie, “Effect of choline and acetate substrates on bifurcation and chaotic behavior of acetylcholine neurocycle and Alzheimer's and Parkinson's diseases,” Chemical Engineering Science, vol. 64, no. 9, pp. 2096–2112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. N. N. Tavares and A. Hassón-Voloch, “Choline acetyltransferase from the electric organ of Electrophorus electricus (L.)—physicochemical characterization and immunochemical identification,” Zeitschrift fur Naturforschung, vol. 53, no. 5-6, pp. 407–415, 1998. View at Google Scholar · View at Scopus
  8. E. P. Brandon, T. Mellott, D. P. Pizzo et al., “Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency,” The Journal of Neuroscience, vol. 24, no. 24, pp. 5459–5466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Zambrzycka, M. Alberghina, and J. B. Strosznajder, “Effects of aging and amyloid-β peptides on choline acetyltransferase activity in rat brain,” Neurochemical Research, vol. 27, no. 4, pp. 277–281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Nunes-Tavares, L. E. Santos, B. Stutz et al., “Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers,” The Journal of Biological Chemistry, vol. 287, no. 23, pp. 19377–19385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Nunes-Tavares, N. L. Cunha-E-Silva, and A. Hassón-Voloch, “Choline acetyltransferase detection in normal and denervated electrocyte from Electrophorus electricus (L.) using a confocal scanning optical microscopy analysis,” Anais da Academia Brasileira de Ciências, vol. 72, no. 3, pp. 331–340, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Raeber, G. Riggio, and P. G. Waser, “Purification and isolation of choline acetyltransferase from the electric organ of Torpedo marmorata by affinity chromatography,” European Journal of Biochemistry, vol. 186, no. 3, pp. 487–492, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Tucek, “Regulation of acetylcholine synthesis in the brain,” The Journal of Neurochemistry, vol. 44, no. 1, pp. 11–24, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. I. H. Mustafa, A. Elkamel, G. Ibrahim, S. S. E. H. Elnashaie, and A. Lohi, “Effect of feed substrate concentrations on dynamic performance of bioethanol fermentation process using Zymomonas mobilis,” Energy & Fuels, vol. 28, no. 8, pp. 5543–5556, 2014. View at Publisher · View at Google Scholar
  15. I. H. Mustafa, A. Elkamel, A. Lohi, G. Ibrahim, and S. S. E. H. Elnashaie, “Structured mathematical modeling, bifurcation, and simulation for the bioethanol fermentation process using Zymomonas mobilis,” Industrial and Engineering Chemistry Research, vol. 53, no. 14, pp. 5954–5972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Craft, L. M. Wein, and D. J. Selkoe, “A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer's brain, CSF and plasma,” Bulletin of Mathematical Biology, vol. 64, no. 5, pp. 1011–1031, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. B. V. Zlokovic, J. Ghiso, J. B. Mackie, J. G. McComb, M. H. Weiss, and B. Frangione, “Blood-brain barrier transport of circulating Alzheimer's amyloid β,” Biochemical and Biophysical Research Communications, vol. 197, no. 3, pp. 1034–1040, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Martel, J. B. Mackic, J. G. McComb, J. Ghiso, and B. V. Zlokovic, “Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs,” Neuroscience Letters, vol. 206, no. 2-3, pp. 157–160, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Nitta, A. Itoh, T. Hasegawa, and T. Nabeshima, “β-Amyloid protein-induced Alzheimer's disease animal model,” Neuroscience Letters, vol. 170, no. 1, pp. 63–66, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. W. A. Pedersen and J. K. Blusztajn, “Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells,” Neuroscience Letters, vol. 239, no. 2-3, pp. 77–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. D. D. Allen, Z. Galdzicki, S. K. Brining, R. Fukuyama, S. I. Rapoport, and Q. R. Smith, “Beta-amyloid induced increase in choline flux across PC12 cell membranes,” Neuroscience Letters, vol. 234, no. 1, pp. 71–73, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Galdzicki, R. Fukuyama, K. C. Wadhwani, S. I. Rapoport, and G. Ehrenstein, “Beta-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease,” Brain Research, vol. 646, no. 2, pp. 332–336, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kar, S. P. M. Slowikowski, D. Westaway, and H. T. J. Mount, “Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease,” Journal of Psychiatry and Neuroscience, vol. 29, no. 6, pp. 427–441, 2004. View at Google Scholar · View at Scopus
  24. K. Duff and F. Suleman, “Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development?” Briefings in Functional Genomics &; Proteomics, vol. 3, no. 1, pp. 47–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Lu, “Integrating experimentation and quantitative modeling to enhance discovery of beta amyloid lowering therapeutics for Alzheimer's disease,” Frontiers in Pharmacology, vol. 3, article 177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Lu, L. Zhang, C. E. Nolan et al., “Quantitative pharmacokinetic/pharmacodynamic analyses suggest that the 129/SVE mouse is a suitable preclinical pharmacology model for identifying small-molecule gamma-secretase inhibitors,” Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 3, pp. 922–934, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. D. Buxbaum, A. A. Ruefli, C. A. Parker, A. M. Cypess, and P. Greengard, “Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 10, pp. 4489–4493, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Ehrenstein, Z. Galdzicki, and G. D. Lange, “The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease,” Biophysical Journal, vol. 73, no. 3, pp. 1276–1280, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. L. B. Hersh and M. Peet, “Re-evaluation of the kinetic mechanism of the choline acetyltransferase reaction,” The Journal of Biological Chemistry, vol. 252, no. 14, pp. 4796–4802, 1977. View at Google Scholar · View at Scopus
  30. P. Garhyan, A. Mahecha-Botero, and S. S. E. H. Elnashaie, “Complex bifurcation/chaotic behavior of acetylcholinesterase and cholineacetyltransferase enzymes system,” Applied Mathematical Modelling, vol. 30, no. 9, pp. 824–853, 2006. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  31. G. Ibrahim and S. S. E. H. Elnashaie, “Hyperchaos in acetylcholinesterase enzyme systems,” Chaos, Solitons & Fractals, vol. 8, no. 12, pp. 1977–2007, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. E. H. Elnashaie, M. A. El-Rifai, and G. Ibrahim, “The effect of hydrogen ion production on the steady-state multiplicity of substrate inhibited enzymatic reactions. II. Transient behavior,” Applied Biochemistry and Biotechnology, vol. 8, p. 467, 1983. View at Google Scholar
  33. S. S. E. H. Elnashaie, M. A. El-Rifai, and G. Ibrahim, “The effect of hydrogen ions on the steady state multiplicity of substrate-inhibited enzymatic reactions. III. Asymmetrical steady-states in enzyme membranes,” Applied Biochemistry and Biotechnology, vol. 9, no. 5-6, pp. 455–474, 1984. View at Publisher · View at Google Scholar
  34. S. S. E. H. Elnashaie, G. Ibrahim, and F. A. Teymour, “Chaotic behaviour of an acetylcholinesterase enzyme system,” Chaos, Solitons & Fractals, vol. 5, no. 6, pp. 933–954, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. C. A. Guyton and J. E. Hall, Textbook of Medical Physiology, W.B. Saunders Company, Amsterdam, The Netherlands, 10th edition, 2000.
  36. S. Tucek, Acetylcholine Synthesis in Neurons, Chapman & Hall, London, UK, 1978.
  37. S. Tucek, “The synthesis of acetylcholine,” in Handbook of Neurochemistry, A. Lajtha, Ed., vol. 4, pp. 219–249, Plenum Press, New York, NY, USA, 2nd edition, 1983. View at Google Scholar
  38. I. López-Coviella, B. Berse, R. Krauss, R. S. Thies, and J. K. Blusztajn, “Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9,” Science, vol. 289, no. 5477, pp. 313–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Kar, A. M. Issa, D. Seto, D. S. Auld, B. Collier, and R. Quirion, “Amylod β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices,” The Journal Neurochemistry, vol. 70, no. 5, pp. 2179–2187, 1998. View at Google Scholar
  40. W.-H. Zheng, S. Bastianetto, F. Mennicken, W. Ma, and S. Kar, “Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures,” Neuroscience, vol. 115, no. 1, pp. 201–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Yung-Chi and W. H. Prusoff, “Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction,” Biochemical Pharmacology, vol. 22, no. 23, pp. 3099–3108, 1973. View at Publisher · View at Google Scholar · View at Scopus
  42. O. F. Olesen, L. Dagø, and J. D. Mikkelsen, “Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells,” Molecular Brain Research, vol. 57, no. 2, pp. 266–274, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Mustafa, A. Elkamel, A. Lohi, P. Chen, S. S. E. H. Elnashaie, and G. Ibrahim, “Application of continuation method and bifurcation for the acetylcholine neurocycle considering partial dissociation of acetic acid,” Computers and Chemical Engineering, vol. 46, pp. 78–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. I. H. Mustafa, G. Ibrahim, A. Elkamel, S. S. E. H. Elnashaie, and P. Chen, “Effect of cholineacetyltransferase activity and choline recycle ratio on diffusion-reaction modeling, bifurcation and chaotic behavior of acetylcholine neurocycle and their relation to Alzheimer's and Parkinson's diseases,” Chemical Engineering Science, vol. 68, no. 1, pp. 19–35, 2012. View at Publisher · View at Google Scholar · View at Scopus